Crossmark

Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial

Crossref DOI link: https://doi.org/10.1038/s41409-018-0138-0

Published Online: 2018-03-07

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jim, Heather S. L. https://orcid.org/0000-0001-7353-3711
Sutton, Steven

Majhail, Navneet S.

Wood, William A.

Jacobsen, Paul B.

Wingard, John R.

Wu, Juan

Knight, Jennifer M.

Syrjala, Karen L.

Lee, Stephanie J. https://orcid.org/0000-0003-2600-6390
License Information

Text and Data Mining valid from 2018-03-07
More Information

Article History

Received: 10 November 2017

Revised: 2 January 2018

Accepted: 9 January 2018

First Online: 7 March 2018

Compliance with ethical standards

:

: HSLJ is a consultant for RedHill Biopharma. The other authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below